Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial
Ning Jiang, Jingyuan Zhang, Zhen Guo, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 1, pp. e008229-e008229
Open Access | Times Cited: 10

Showing 10 citing articles:

The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patients with unresectable locally advanced esophageal squamous cell carcinoma
R. Wang, Tianhui Guo, Qi Wang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Neoadjuvant Immunochemotherapy with or Without Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Pooled Analysis of Two Prospective Single-Arm Clinical Trials
Yixin Li, Ming Jiang, Zihao Zhu, et al.
(2025)
Closed Access
Neoadjuvant chemoradiotherapy plus sequential tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): A single-arm, bicentric, phase 2 trial
Jinsong Yang, Cui Liu, Zhigang Zuo, et al.
Radiotherapy and Oncology (2025), pp. 110797-110797
Closed Access
Targeting esophageal carcinoma: molecular mechanisms and clinical studies
Wenjing Wang, Lisha Ye, Huihui Li, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 3
Radical chemoradiotherapy for superficial esophageal cancer complicated with liver cirrhosis
Hejing Bao, Hehong Bao, Liping Lin, et al.
PeerJ (2024) Vol. 12, pp. e18065-e18065
Open Access | Times Cited: 1
Electronic patient-reported outcome-based surveillance system to evaluate safety and efficacy of preoperative immunochemotherapy with or without short-term chemoradiation in patients with esophageal squamous cell carcinoma (ePRO-PICCRT): protocol for a prospective, single-arm, phase II study
Shujie Huang, Hongfan Yu, Zijie Li, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 7, pp. 4719-4726
Open Access
Pathologic response evaluation of localized or locally advanced esophageal carcinoma to induction chemotherapy followed by preoperative concurrent chemotherapy and hypofractionated radiotherapy: a clinical trial
Ali Emadi Torghabeh, Seyed Amir Aledavood, Ehsan Soltani, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Mid-term follow-up results of neoadjuvant sintilimab combined with chemotherapy for locally advanced resectable esophageal squamous cell carcinoma
Haibo Cai, Lei Chen, Junjun Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
PROTOCOL: Immunomodulatory Low-dose Radiotherapy Combined with Chemoimmunotherapy for Conversion Therapy of Locally Advanced Borderline/Potentially Resectable Esophageal Squamous Cell Carcinoma: A Single Arm, Single Center, Prospective Trial (ROICE Trial)
Wei Ren, Wu Sun, Qi Sun, et al.
Research Square (Research Square) (2024)
Closed Access
Current status and perspectives of esophageal cancer: a comprehensive review
Wei Jiang, Bo Zhang, Jiaqi Xu, et al.
Cancer Communications (2024)
Open Access
Page 1

Scroll to top